Xpeng’s next-gen Iron humanoid robot during AI Day at its headquarters in Guangzhou, China, on November 5, 2025.

...

Newsweek Editors

By Newsweek Editors

0

Share

Newsweek is a Trust Project member

See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.


At a U.S.-Saudi investment forum last month, Elon Musk, father of 14 children, said that in an AI-rich future only 10 or 20 percent of people will need a job, with most work handled by robots—a world he’s framed as compatible with some form of "universal high income." He meant it as a benign future scenario. Within days, Beijing offered a real-world stress test for that scenario.

China announced it will add a 13 percent tax to condoms and other contraceptives—ending a three-decade exemption—just as a Shenzhen robotics firm signed $37 million deal to deploy humanoids at border crossings near Vietnam. The robots will guide travelers, haul boxes, and even swap their own batteries. Births in China, meanwhile, are still running below deaths. In other words: Beijing is taxing the prophylactics, buying the androids, and seeing what happens next.

Musk’s line about work becoming optional is striking for how it meets China’s current experiment: if you can make labor cheap by making robots cheaper, the birthrate arithmetic changes quickly. In fact, China says you can now order a humanoid (Unitree R1) for about $5,566, a price that undercuts the $16,000 midrange Unitree G1 and comes in well below high-end models listing around $90,000. It’s estimated that it can cost roughly $100,000 in public outlays to generate one additional U.S. birth. Bots are becoming cheaper than babies.

Read More on News

Common Knowledge

On the American left, pronatalism tied to nationalism is viewed as coercive: commentators warn it prioritizes demographics over women’s autonomy and note that birth rates respond more to housing, child care and paid leave than to rhetoric or cash incentives. The socialist left adds that the U.S. "NatalCon" scene is ideologically split (such as on the use of IVF) and lacks an evidence-backed plan to lift fertility.

On the right, pro-family commentators argue low fertility is an urgent fiscal and social problem worth spending money on—pointing to international evidence that cash-like benefits can raise births, though at high cost and with effects that may time-shift rather than transform lifetime fertility.

Uncommon Knowledge

The pronatalism debate is fraught but its genesis lies in some challenging realities. China’s 2024 births (9.54 million) ticked up, but deaths (10.93 million) still outpaced them, shrinking the population for a third straight year to 1.408 billion. U.N. estimates put China’s total fertility rate near 1.2—far below replacement. Robots, by contrast, are proliferating: China could account for roughly half of global humanoid sales in 2025. Automation looks like a policy with fast, measurable returns; encouraging more births is expensive and slow.

The United States faces a similar problem without the centralized levers. CDC data shows the U.S. fertility rate hit a record low in 2024 (about 1.60). The country relies on immigration, unlike China, and productivity gains to square the circle. Which is why the Musk thesis feels seductive to parts of the right and to tech centrists. Yet the arithmetic that makes bots look cheap also hides something: children eventually become workers, innovators, taxpayers—robots don’t pay payroll taxes, and someone must buy, power, and maintain them.

If you pay $30 an hour, the cost of one full-time American worker can hit nearly $100,000 once taxes and extras are included. To keep one shift permanently covered, you might need four people.

A robot, by contrast, is in theory mostly a purchase. There are Chinese humanoids at roughly $6,0000 (entry level), $16,000 (midrange), the oft-floated $20,000 to $30,000 target for the next wave, and a $90,000 higher-end unit. Of course, it’s not that simple. Robots will still need human supervision and cost in maintenance and energy use. Those are big cost unknowns.

So, at least in the short term, countries want more births. That’s why China’s VAT revamp, effective January 1, 2026, pulls contraceptives into the 13 percent bracket, reversing the 1993 exemption that aligned with its old one-child policy. By itself, a 13 percent levy on condoms won’t reverse fertility trends. But it buys time. Raise the cost of contraception until humanoids become ubiquitous at ports, factories, and shop floors.

China is making that bet explicit. The U.S. is making it by drift: a record-low fertility rate, a stop-start debate over the Child Tax Credit, and a private sector, led by Tesla, racing to automate anyway. The robots are here, but the policy choices, at least in the U.S., are not.


If you’re enjoying Uncommon Knowledge, please share. If you have suggestions for future editions or feedback, email subscriber.feedback@newsweek.com. We want to hear your voice.

View 0 Comments

Request Reprint & Licensing

Submit Correction

View Editorial & AI Guidelines